ATE163939T1 - Peptide und antikörper zur behandlung von rheumatoider arthritis. - Google Patents

Peptide und antikörper zur behandlung von rheumatoider arthritis.

Info

Publication number
ATE163939T1
ATE163939T1 AT92923909T AT92923909T ATE163939T1 AT E163939 T1 ATE163939 T1 AT E163939T1 AT 92923909 T AT92923909 T AT 92923909T AT 92923909 T AT92923909 T AT 92923909T AT E163939 T1 ATE163939 T1 AT E163939T1
Authority
AT
Austria
Prior art keywords
peptides
antibodies
treatment
rheumatoid arthritis
necessarily adjacent
Prior art date
Application number
AT92923909T
Other languages
English (en)
Inventor
Julian Kirby
Ian Victor Lewin
Sarita Maman
Denis Raymond Stanworth
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Application granted granted Critical
Publication of ATE163939T1 publication Critical patent/ATE163939T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92923909T 1991-11-25 1992-11-25 Peptide und antikörper zur behandlung von rheumatoider arthritis. ATE163939T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125024A GB9125024D0 (en) 1991-11-25 1991-11-25 Rheumatoid arthritus treatment

Publications (1)

Publication Number Publication Date
ATE163939T1 true ATE163939T1 (de) 1998-03-15

Family

ID=10705197

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92923909T ATE163939T1 (de) 1991-11-25 1992-11-25 Peptide und antikörper zur behandlung von rheumatoider arthritis.

Country Status (10)

Country Link
EP (1) EP0614464B1 (de)
JP (1) JPH07507045A (de)
AT (1) ATE163939T1 (de)
AU (2) AU2951392A (de)
CA (1) CA2123694A1 (de)
DE (1) DE69224750D1 (de)
ES (1) ES2112921T3 (de)
FI (1) FI942392A0 (de)
GB (2) GB9125024D0 (de)
WO (1) WO1993011153A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416864D0 (en) * 1994-08-19 1994-10-12 Peptide Therapeutrics Limited Treatment of IgA nephropathy
GB9416865D0 (en) * 1994-08-19 1994-10-12 Peptide Therapeutrics Limited Treatment of inflammatory diseases of the gastro-intestinal tract
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
CA2245497C (en) 1996-03-01 2009-02-24 Novartis Ag Peptide immunogens for vaccination against and treatment of allergy
WO2001098540A2 (en) * 2000-06-22 2001-12-27 San Diego State University Foundation Recombination modulators and methods for their production and use
AU2009262199B2 (en) 2008-06-27 2012-08-09 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
US11918624B2 (en) 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
US4701416A (en) * 1983-12-09 1987-10-20 Cetus Corporation Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
US4692511A (en) * 1984-07-03 1987-09-08 Immunetech Pharmaceuticals Peptide antagonists for the C5a anaphylatoxin
DE3685651T2 (de) * 1985-12-26 1993-01-21 Univ Saskatchewan Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
GB8616174D0 (en) * 1986-07-02 1986-08-06 Antibody Technology Ltd Monoclonal antibodies
DK268889A (da) * 1988-06-07 1989-12-08 Smithkline Beckman Corp Cykliske d-cys6-peptidforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
GB2220939B (en) * 1988-06-10 1992-02-26 Medical Res Council Peptide fragments of hiv and their use in vaccines and diagnosis
FR2646425B1 (fr) * 1989-04-26 1991-08-30 Neosystem Sa Peptides synthetiques du conjugue de l'ubiquitine et de l'histone h2a
JP3058685B2 (ja) * 1989-05-08 2000-07-04 アイデックス ラボラトリーズ インコーポレーテッド ネコｔ細胞リンパトロピック レンチウィルスのポリペプチド
EP0605410B1 (de) * 1990-05-25 1995-08-16 Peptide Therapeutics Limited Immunodiagnostische probe für gelenkrheumatismus
CA2060699A1 (en) * 1991-02-11 1992-08-12 Isia Bursuker Gm-csf inhibiting oligopeptides

Also Published As

Publication number Publication date
AU2951392A (en) 1993-06-28
GB2261665B (en) 1995-11-08
GB2261665A (en) 1993-05-26
WO1993011153A1 (en) 1993-06-10
JPH07507045A (ja) 1995-08-03
FI942392A7 (fi) 1994-05-24
EP0614464A1 (de) 1994-09-14
EP0614464B1 (de) 1998-03-11
FI942392L (fi) 1994-05-24
ES2112921T3 (es) 1998-04-16
FI942392A0 (fi) 1994-05-24
CA2123694A1 (en) 1993-06-10
AU7196596A (en) 1997-02-06
GB9224684D0 (en) 1993-01-13
DE69224750D1 (de) 1998-04-16
GB9125024D0 (en) 1992-01-22

Similar Documents

Publication Publication Date Title
DE69630133D1 (de) Analoga des parathyroid-hormons
PT89961A (pt) Processo para a preparacao de n-carboxianidridos de aminoacidos protegidos por uretano
DE69532996D1 (de) Peptidanaloge des menschlichen basischen myelinproteins
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
DE69129865D1 (de) Osteogene peptide
DE3585556D1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
FI954978A0 (fi) Modifioidut proteiini- ja peptidilääkeaineet
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
ES2174770T1 (es) Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide.
ATE100714T1 (de) Arzneimittel (calcitoningen verwandte peptide) zur behandlung erektiler dysfunktionen.
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
BR9306272A (pt) Peptídeo e composiçao farmacêutica
DE69224750D1 (de) Peptide und Antikörper zur Behandlung von rheumatoider Arthritis.
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
DE69940927D1 (de) PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT
ES2087337T3 (es) Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos.
EP0846950A3 (de) Peptide brauchbar als Mikrosequenzierungsstandard und Verfahren zu derer Anwendung
ATE31418T1 (de) Arzneimittel, welche tripeptide enthalten.
ATE93527T1 (de) Peptide und deren benutzung.
ATE92078T1 (de) Pharmakologisch aktive peptide.
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DK34590D0 (da) Biologisk aktive molekyler
ATE112290T1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
KR920700224A (ko) 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties